TARRYTOWN, N.Y.--(BUSINESS WIRE)--Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) will webcast its presentation at the 29th Annual Canaccord Adams Global Growth Conference on Wednesday, August 12, 2009. The presentation, which is scheduled for 2:30 p.m. Eastern Time, will provide an overview of the Company, including its three Phase 3 clinical programs. The session may be accessed through the Company’s web site, www.regeneron.com, on the Investor Relations page under the Presentations heading. An archived version of the presentation will be available after the live webcast through September 11, 2009. Additional information about Regeneron and recent news releases are available on the Regeneron web site.
